Papers
2
Total Citations
42
H-Index
2
About
Dr. Edoardo Mercadante is a pioneering thoracic surgeon whose research centers on advancing minimally invasive surgical techniques for lung cancer treatment, with a particular focus on robotic-assisted thoracic surgery (RATS). His major contributions include demonstrating that robotic-assisted lobectomy achieves comparable or superior nodal upstaging—a critical measure of oncologic thoroughness—compared to traditional video-assisted thoracoscopic surgery (VATS) and thoracotomy for early-stage non-small cell lung cancer, as shown in his highly cited 2021 study (28 citations). Dr. Mercadante also broke new ground with his early experience in uniportal robotic thoracic surgery lobectomy (14 citations), a technique that reduces invasiveness to a single incision, potentially improving patient recovery and outcomes. His work has been instrumental in validating the role of robotics in thoracic oncology, challenging conventional approaches and expanding surgical options. With a growing citation impact and a reputation for innovation, Dr. Mercadante continues to shape the future of lung cancer surgery, making him a key figure for students and researchers interested in the intersection of technology, precision, and patient-centered care.
Research Focus
Key Achievements
Top Papers
- 1
- 2Early experience with uniportal robotic thoracic surgery lobectomy14 citations · 2022